Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treatment of Diarrhea-Associated Fecal Incontinence With Eluxadoline

Trial Profile

Treatment of Diarrhea-Associated Fecal Incontinence With Eluxadoline

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Dec 2018

At a glance

  • Drugs Eluxadoline (Primary)
  • Indications Diarrhoea; Faecal incontinence
  • Focus Therapeutic Use
  • Acronyms ELXDFI
  • Most Recent Events

    • 03 Dec 2018 Planned initiation date changed from 30 Aug 2018 to 1 Jan 2019.
    • 23 Jul 2018 Planned initiation date changed from 1 May 2018 to 30 Aug 2018.
    • 10 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top